194 related articles for article (PubMed ID: 34135582)
1. Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer.
Li Q; Lin B; Li Y; Lu N
Int J Nanomedicine; 2021; 16():3875-3887. PubMed ID: 34135582
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer.
Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z
J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964
[TBL] [Abstract][Full Text] [Related]
3. Cancer Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Therapy on Breast Cancer via Autophagy Regulation Strategy.
Feng Q; Yang X; Hao Y; Wang N; Feng X; Hou L; Zhang Z
ACS Appl Mater Interfaces; 2019 Sep; 11(36):32729-32738. PubMed ID: 31415145
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Targeted Mesoporous Titanium Dioxide Nanoplatform for Synergistic Nitric Oxide Gas-Sonodynamic Therapy of Breast Cancer.
Zuo S; Zhang Y; Wang Z; Wang J
Int J Nanomedicine; 2022; 17():989-1002. PubMed ID: 35280333
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species-Manipulated Drug Release from a Smart Envelope-Type Mesoporous Titanium Nanovehicle for Tumor Sonodynamic-Chemotherapy.
Shi J; Chen Z; Wang B; Wang L; Lu T; Zhang Z
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28554-65. PubMed ID: 26587885
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell membrane-coated C-TiO
Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell membrane-enveloped O
Li C; Yang XQ; An J; Cheng K; Hou XL; Zhang XS; Hu YG; Liu B; Zhao YD
Theranostics; 2020; 10(2):867-879. PubMed ID: 31903156
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
9. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
11. Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma.
Zhang D; Zheng A; Li J; Wu M; Wu L; Wei Z; Liao N; Zhang X; Cai Z; Yang H; Liu G; Liu X; Liu J
Theranostics; 2017; 7(1):164-179. PubMed ID: 28042325
[TBL] [Abstract][Full Text] [Related]
12. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
13. Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer.
Chen J; Luo H; Liu Y; Zhang W; Li H; Luo T; Zhang K; Zhao Y; Liu J
ACS Nano; 2017 Dec; 11(12):12849-12862. PubMed ID: 29236476
[TBL] [Abstract][Full Text] [Related]
14. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
15. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
16. Safe and Targeted Sonodynamic Cancer Therapy Using Biocompatible Exosome-Based Nanosonosensitizers.
Nguyen Cao TG; Kang JH; You JY; Kang HC; Rhee WJ; Ko YT; Shim MS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25575-25588. PubMed ID: 34033477
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable Nanosonosensitizers with the Multiple Modulation of Tumor Microenvironment for Enhanced Sonodynamic Therapy.
Zhou H; Sun J; Wu J; Wei H; Zhou X
Int J Nanomedicine; 2021; 16():2633-2646. PubMed ID: 33854312
[TBL] [Abstract][Full Text] [Related]
18. Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy.
Han X; Zhou C; Luo X; Pang H; Han C; Tang L; Yang Z; Nong Y; Lu C
Curr Mol Med; 2024; 24(5):648-666. PubMed ID: 37312441
[TBL] [Abstract][Full Text] [Related]
19. Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy.
Kim S; Im S; Park EY; Lee J; Kim C; Kim TI; Kim WJ
Nanomedicine; 2020 Feb; 24():102110. PubMed ID: 31666202
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
